In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
AUTOR(ES)
Chirgwin, K
RESUMO
The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172720Documentos Relacionados
- Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR).
- In vitro drug susceptibility of Chlamydia sp. strain TWAR.
- Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR.
- Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR.
- A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis.
